OQROGet OQRO Pro
Insider trade

Definium Therapeutics (DFTX)Chief Legal Officer sold ~$34K

Mark Sullivan, Chief Legal Officer at Definium Therapeutics, sold ~$34K of Definium Therapeutics shares.

~$34K
Approx. value · 4,519 sh @ $7.43
173K
Holds after · shares reported
Traded
Dec 26, 2024
Filed
Dec 27, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 5, 2024InsiderDirector purchased ~$18K of DFTX shares in the open market
  2. Dec 26, 2024 · this disclosureInsiderOfficer sold ~$34K of DFTX shares in the open market

What came next

  1. Dec 26, 2024Insider · 3 peopleInsiders: 3 sales (~$208K)
  2. Mar 25, 2025Insider · 4 peopleInsiders: 4 sales (~$249K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Definium Therapeutics

For Definium Therapeutics, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 8 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DFTX page.

Other recent filings by Mark Sullivan, Chief Legal Officer

The full history of Mark Sullivan, Chief Legal Officer is on the profile page.

How this filing works

Other disclosures at Definium Therapeutics

Everything OQRO holds on this company is on its DFTX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data